News Mar 07, 2025
DCAT Week 2025 — The Premier Event Connecting Biotech and Pharmaceutical Industries
DCAT Week is the premier annual event for the biotechnology and pharmaceutical manufacturing value chain. With senior decision-makers in attendance, it provides a unique platform for healthcare companies of all sizes to conduct high-level business meetings and foster strategic partnerships.
News Mar 07, 2025
Porton Wins Outsourced Pharma 2025 CDMO Leadership Award
In March 2025, Porton Pharma Solutions Ltd. was honored with the "Global Small Molecule API Award" at the 14th Outsourced Pharma CDMO Leadership Awards, recognizing its exceptional end-to-end services across the global small molecule drug lifecycle. This award reaffirms Porton's outstanding performance in the CDMO sector for pharmaceutical R&D and manufacturing worldwide.
NewslettersMar 06, 2025
Porton Newsletter - Jan. to Feb. 2025 Recap
Technical Enabling Technical Solutions for PROTAC Drugs Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
News Feb 28, 2025
Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025
Porton Pharma Solutions will once again participate in BIO-Europe Spring 2025, held from March 17th to 19th, at booth #87.
News Feb 13, 2025
Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts
Porton Pharma Solutions is thrilled to announce its participation in several major industry events across the globe during the first and second quarters of 2025. As a leading end-to-end integrated CDMO company, Porton boasts globally advanced technology platforms and extensive project delivery experience in small molecules, peptides and oligonucleotides, ADCs (including antibodies, payload-linkers, conjugation, and drug product filling), and Advanced Therapy Medicinal Products.
News Jan 28, 2025
Our Incredible Journey in 2024
Under open skies, the years pass endlessly. As the sun rises, Porton welcomes a new year with sincerity and hope. Reflecting on 2024, we faced challenges together, standing strong and united, achieving great heights.
News Jan 14, 2025
Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
Recently, the Porton Biologics and Conjugates Platform successfully completed the GMP contract manufacturing of three batches of sterile drug products for a client at our R&D and production facility in Pudong, Shanghai. This milestone marks a significant step forward for our Biologics and Conjugates CDMO platform—a testament to our unwavering commitment to quality and reliability.
News Jan 03, 2025
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that it scored 44 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment reflecting an improvement of 6 points over the previous assessment, where scores in all the three dimensions getting improved. (CSA Score as of 27/11/2024).
News Dec 23, 2024
Porton Pharma Solutions and Dragon Sail Pharmaceutical Form Strategic Partnership
On December 20, 2024, Porton Pharma Solutions Ltd. (hereinafter referred to as “Porton Pharma Solutions” or “Porton”) and Dragon Sail Pharmaceutical (Shanghai) Co., Ltd. (a subsidiary of Guilin Sanjin, hereinafter referred to as “Dragon Sail Pharmaceutical”) formally signed a strategic cooperation agreement in Guilin, southern of China.
